Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Reprod Toxicol. 2012 Mar 10;34(1):22–30. doi: 10.1016/j.reprotox.2012.03.001

Table 2.

Female Body Weight

C57BL/6
Wks Control EE 0.01ppm EE 0.1ppm EE 1.3ppm BPA 0.03ppm BPA 0.3ppm BPA 30ppm
0 14.4 ± 0.6 14.1 ± 0.4 14.4 ± 0.4 14.7 ± 0.6 14.3 ± 0.8 13.7 ± 0.9 14.2 ± 0.9
1 15.5 ± 0.6 15.4 ± 0.9 14.0 ± 0.4 13.1 ± 0.4a 16.1 ± 0.8 15.8 ± 0.6 16.4 ± 1.8
2 16.5 ± 0.6 15.7 ± 0.9 14.7 ± 0.9a 13.2 ± 1.0a 16.6 ± 0.7 16.1 ± 0.7 16.4 ± 0.6
3 17.5 ± 1.0 16.3 ± 1.3 14.6 ± 0.7a 13.3 ± 0.7a 17.8 ± 0.9 17.3 ± 0.4 17.2 ± 0.3
Status gravida nulli
gravida 		gravida nulli
gravida 		gravida nulli
gravida 		gravida nulli
gravida 		gravida nulli
gravida 		gravida nulli
gravida 		gravid nulli
gravida
4 17.9 ± 0.9 17.1 ± 0.4 15.2 16.3 ± 1.1 NA 14.7 ± 0.8 NA 12.8 ± 0.9 18.2 ± 0.6 17.0 ± 0.5 17.7 ± 0.4 17.2 ± 0.6 17.6 ± 0.3 16.4
5 19.8 ± 1.1 19.0 ± 0.8 15.9 17.3 ± 1.5 NA 15.4 ± 0.4 NA 13.1 ± 1.5 19.9 ± 0.8 18.1 ± 1.2 19.7 ± 0.7 18.8 ± 0.0 19.7 ± 0.6 17.6
6 26.4 ± 1.7 20.4 ± 0.2 17.1 19.2 ± 0.6 NA 15.4 ± 1.1 NA 13.1 ± 0.6 25.5 ± 0.2 19.3 ± 0.1 26.6 ± 2.6 20.1 ± 0.1 26.7 ± 3.0 18.9
7 24.3 ± 0.8 21.2 ± 1.1 18.2 20.2 ± 2.0 NA 16.2 ± 0.6 NA 13.5 ± 1.3 32.3 ± 8.5 21.4 ± 0.2 27.8 ± 6.1 21.7 ± 1.2 26.3 ± 4.7 19.6
CD1
Wks Control EE 0.01ppm EE 0.1ppm EE 1.3ppm BPA 0.03ppm BPA 0.3ppm BPA 30ppm
0 20.1 ± 1.4 20.8 ± 0.6 19.9 ± 0.7 20.2 ± 1.7 20.3 ± 0.9 19.6 ± 1.3 19.3 ± 1.4
1 22.5 ± 1.2 24.0 ± 1.2 20.8 ± 1.7 18.6 ± 1.4a 23.3 ± 1.0 23.4 ± 2.7 23.7 ± 1.6
2 24.6 ± 1.5 26.6 ± 1.8 21.8 ± 1.7 18.7 ± 1.3a 25.4 ± 2.0 26.4 ± 4.2 27.0 ± 3.4
3 23.6 ± 1.0 25.0 ± 1.6 21.3 ± 1.3 18.3 ± 1.1a 24.0 ± 1.8 25.5 ± 3.2 25.6 ± 2.3
Status gravida nulli
gravida 		gravida nulli
gravida 		gravida nulli
gravida 		gravida nulli
gravida 		gravida nulli
gravida 		gravida nulli
gravida 		gravida nulli
gravida
4 26.0 ± 1.3 NA 27.9 ± 1.5 26.4 ± 2.0 NA 22.5 ± 1.2 NA 19.0 ± 1.4 25.2 ± 2.3 27.3 ± 2.6 27.4 ± 3.0 25.6 ± 2.8 26.8 ± 0.5 29.7
5 33.6 ± 2.4 NA 35.7 ± 6.2 31.2 ± 0.5 NA 23.0 ± 1.3 NA 19.3 ± 1.3 32.3 ± 5.1 29.0 ± 3.2 32.1 ± 1.3 26.5 ± 2.3 34.3 ± 1.9 29.6
6 53.4 ± 5.2 NA 33.7 ± 3.4 32.9 ± 3.5 NA 24.1 ± 2.4 NA 19.4 ± 1.4 47.6 ± 13.3 31.8 ± 4.2 45.6 ± 8.2 27.6 ± 3.2 33.7 ± 1.6 32.7
7 35.5 ± 2.7 NA 36.0 ± 0.8 32.2 NA 29.1 ± 1.9 NA 19.9 37.1 ± 1.6 34.8 ± 4.5 38.5 ± 1.0 38.5 ± 3.9 36.5 ± 2.8 37.9

Values represent group mean ± SD;

a

Significantly different from Control by one-way ANOVA (p < 0.05). Weeks 4–7 of treatment are separated by those F0 females that produced a live litter (Gravida) and those that did not produce a live litter (Nulligravida).